Malaria drug 'shows promise' for hard-to-treat multiple sclerosis

Hydroxychloroquine, which is also used to treat rheumatoid arthritis, delayed the progression of disability in some MS patients.

Related Keywords

Marcus Koch ,Donald Trump ,University Of Calgary ,Department Of Clinical Neurosciences ,Clinical Neurosciences ,